A Short Biography:
Dr. Hermes Garban�s research focuses on three major areas: molecular tumor immunobiology, regulation of gene expression and nitric oxide biology and signaling. Tumor immune-tolerance is one of multiple mechanisms utilized by cancer cells in order to evade the immune system. Garban�s laboratory studies the molecular mechanisms involved in the tumor-dependent modulation of immune-tolerance and tumor resistance to programmed cell death or apoptosis. Their central hypothesis is that cancer cells are acquiring a new profile of gene expression by the activation of genetic and/or epigenetic signals that are directing the survival of cancer cells even in a perfectly normal immunocompetent environment. Thus, determining the mechanisms of control of these ectopically expressed genes (i.e., FOXP3, ROBO4, COX2, YY1, TRAF6, Survivin, etc.) and their role in tumor-derived immune-tolerance and resistance to apoptosis will provide new insight in the mechanisms of tumor immune evasion, define better-targeted immunotherapy strategies and improve the effectiveness of conventional therapies against cancer. In addition, Garban�s lab is interested in studying the role of Nitric Oxide (NO) and other reactive oxygen species (ROS) in the regulation of gene expression in the above-mentioned paradigm.
Publications:
A selected list of publications:
Vo Dan D, Prins Robert M, Begley Jonathan L, Donahue Timothy R, Morris Lilah F, Bruhn Kevin W, de la Rocha Pilar, Yang Meng-Yin, Mok Stephen, Garban Hermes J, Craft Noah, Economou James S, Marincola Francesco M, Wang Ena, Ribas Antoni
Enhanced antitumor activity induced by adoptive T-cell transfer and
adjunctive use of the histone deacetylase inhibitor LAQ824
Cancer research,
2009; 69(22):
8693-9.
Begley Jonathan, Vo Dan D, Morris Lilah F, Bruhn Kevin W, Prins Robert M, Mok Stephen, Koya Richard C, Garban Hermes J, Comin-Anduix Begonya, Craft Noah, Ribas Antoni
Immunosensitization with a Bcl-2 small molecule inhibitor
Cancer immunology, immunotherapy : CII,
2009; 58(5):
699-708.
Ribas Antoni, Vo Dan D, Weeks David L, Comin-Anduix Begoña, Schumacher Lana Y, Garban Hermes J, McLean Colin, Yang Jinquan, Dissette Vivian B, Peraza Pedro, Owens Sharla K, McBride William H, Glaspy John A, Economou James S
Broad antitumor protection by dendritic cells administered to CD8alpha
knock out mice
Cancer immunology, immunotherapy : CII,
2006; 55(6):
663-71.
Schumacher Lana Y, Vo Dan D, Garban Hermes J, Comin-Anduix Begoña, Owens Sharla K, Dissette Vivian B, Glaspy John A, McBride William H, Bonavida Benjamin, Economou James S, Ribas Antoni
Immunosensitization of tumor cells to dendritic cell-activated immune
responses with the proteasome inhibitor bortezomib (PS-341, Velcade)
Journal of immunology (Baltimore, Md. : 1950),
2006; 176(8):
4757-65.
Seligson David, Horvath Steve, Huerta-Yepez Sara, Hanna Stephanie, Garban Hermes, Roberts Alice, Shi Tao, Liu Xueli, Chia David, Goodglick Lee, Bonavida Benjamin
Expression of transcription factor Yin Yang 1 in prostate cancer
International journal of oncology,
2005; 27(1):
131-41.